BACKGROUND: Neuropsychiatric symptoms (NPS) are common in patients with mild cognitive impairment (MCI). Little is known, however, about how NPS vary by MCI subtype (i.e. amnestic, single domain non-memory, and multiple domain). In addition, it is unclear whether NPS increase risk of progression to dementia. We investigated the distribution of NPS across MCI subtypes and determined whether NPS increase risk of progression to dementia. METHOD: Participants were 521 patients diagnosed with MCI at the Alzheimer's Research Centers of California between 1988 and 1999. At baseline, patients were classified into MCI subtypes and were assessed for NPS. RESULTS: The mean number of NPS was 2.3 (range 0-9.6; 74% had > or =1 NPS). Patients with > or =4 NPS had more medical comorbidities and greater functional impairment (p < or = 0.0001 for both). Patients with > or =4 NPS were more likely than patients with 0-3 NPS to have amnestic MCI (81% vs 71%, respectively, p = 0.03), and patients with amnestic MCI were more likely than those with other subtypes to exhibit depressive symptoms. Patients with > or =4 NPS had nearly 2.5 times the odds of developing dementia at follow-up than patients with 0-3 NPS (adjusted OR = 2.44, 95% CI 1.07, 5.55). CONCLUSION: NPS are common in MCI patients. Those with an elevated number of NPS may be more likely to have the amnestic subtype of MCI, and depression may be more common in amnestic MCI than in other subtypes. An elevated number of NPS may increase risk of progression to dementia for patients with MCI.
BACKGROUND:Neuropsychiatric symptoms (NPS) are common in patients with mild cognitive impairment (MCI). Little is known, however, about how NPS vary by MCI subtype (i.e. amnestic, single domain non-memory, and multiple domain). In addition, it is unclear whether NPS increase risk of progression to dementia. We investigated the distribution of NPS across MCI subtypes and determined whether NPS increase risk of progression to dementia. METHOD:Participants were 521 patients diagnosed with MCI at the Alzheimer's Research Centers of California between 1988 and 1999. At baseline, patients were classified into MCI subtypes and were assessed for NPS. RESULTS: The mean number of NPS was 2.3 (range 0-9.6; 74% had > or =1 NPS). Patients with > or =4 NPS had more medical comorbidities and greater functional impairment (p < or = 0.0001 for both). Patients with > or =4 NPS were more likely than patients with 0-3 NPS to have amnestic MCI (81% vs 71%, respectively, p = 0.03), and patients with amnestic MCI were more likely than those with other subtypes to exhibit depressive symptoms. Patients with > or =4 NPS had nearly 2.5 times the odds of developing dementia at follow-up than patients with 0-3 NPS (adjusted OR = 2.44, 95% CI 1.07, 5.55). CONCLUSION: NPS are common in MCI patients. Those with an elevated number of NPS may be more likely to have the amnestic subtype of MCI, and depression may be more common in amnestic MCI than in other subtypes. An elevated number of NPS may increase risk of progression to dementia for patients with MCI.
Authors: H Feldman; P Scheltens; E Scarpini; N Hermann; P Mesenbrink; L Mancione; S Tekin; R Lane; S Ferris Journal: Neurology Date: 2004-04-13 Impact factor: 9.910
Authors: Yonas E Geda; Glenn E Smith; David S Knopman; Bradley F Boeve; Eric G Tangalos; Robert J Ivnik; David A Mrazek; Steven D Edland; Ronald C Petersen Journal: Int Psychogeriatr Date: 2004-03 Impact factor: 3.878
Authors: Christopher C Colenda; Claudine Legault; Stephen R Rapp; Margaret W DeBon; Patricia Hogan; Robert Wallace; Linda Hershey; Judith Ockene; Rachael Whitmer; Lawrence S Phillips; Gloria E Sarto Journal: Am J Geriatr Psychiatry Date: 2010-02 Impact factor: 4.105
Authors: Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller Journal: Alzheimers Dement Date: 2011-09 Impact factor: 21.566
Authors: John M Ringman; Li-Jung Liang; Yan Zhou; Sitaram Vangala; Edmond Teng; Sarah Kremen; David Wharton; Alison Goate; Daniel S Marcus; Martin Farlow; Bernardino Ghetti; Eric McDade; Colin L Masters; Richard P Mayeux; Martin Rossor; Stephen Salloway; Peter R Schofield; Jeffrey L Cummings; Virginia Buckles; Randall Bateman; John C Morris Journal: Brain Date: 2015-02-15 Impact factor: 13.501
Authors: R Scott Mackin; Philip Insel; Paul S Aisen; Yonas E Geda; Michael W Weiner Journal: Int J Geriatr Psychiatry Date: 2011-07-08 Impact factor: 3.485
Authors: K Duff; J Paulsen; J Mills; L J Beglinger; D J Moser; M M Smith; D Langbehn; J Stout; S Queller; D L Harrington Journal: Neurology Date: 2010-07-07 Impact factor: 9.910